Skip to Main Content

Paper Details

The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia.
Blood Sci
2
2022
Author NameAffiliation
Dong LinNational Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
  • 1 - 1

Datasets

Release 1.2